Is MRI diffusion-weighted imaging a reliable tool for the diagnosis and posttherapeutic follow-up of extremity soft tissue neoplasms?

Abstract

Purpose: The aim of this study was to evaluate the benefit of using quantitative diffusion-weighted imaging (DWI) with apparent diffusion coefficient (ADC) mapping in the initial diagnosis and post-therapeutic follow-up of extremity soft tissue masses. Patients and Methods: This study included 90 patients with extremity soft tissue masses. The DWI was obtained with 3 b values, including 0, 400, and 800 s/mm². Calculation of the ADC value of the lesion was done by placing the region of interest (ROI) to include the largest area of the lesion. ADC values were compared with the histopathology. Eighteen patients had posttherapeutic magnetic resonance imaging (MRI). Results: Benign masses, fibromatosis, and malignant soft tissue masses had mean ADC values of 1.18 ± 1.0191 × 10⁻³ mm²/s; 1.31 ± 0.245 × 10⁻³ mm²/sec; and 1.3 ± 0.7 × 10⁻³ mm²/s, respectively. Myxomatous malignant masses had an ADC value of 2.6 ± 0.55 × 10⁻³ mm²/s, while nonmyxomatous malignant masses had an ADC value of 1.1 ± 0.8 × 10⁻³ mm²/s. ADC cutoff value between benign and non-benign (including malignant and locally aggressive masses) was 0.6 × 10⁻³ mm²/sec with 98.3% sensitivity and 50% specificity (P = 0.5123). The statistical difference between malignant soft tissue masses (mean ADC 1.309 ± 0.723 × 10⁻³ mm²/s) and fibromatosis masses (mean ADC value 1.31 ± 0.245 × 10⁻³ mm²/s) using a comparative T-test proved to be of poor significance level (P value ~ 0.9757). Nine patients with soft tissue sarcomas (STSs) had pre and post-therapeutic MRI examinations showing a mean increase of the recorded ADC values by about 0.28 × 10⁻³ mm²/s in the post-therapy study as compared with the recorded initial pretreatment values. Analysis of the post-therapy follow-up studies of fibromatosis showed that lesions with favorable response to chemotherapy or radiotherapy (8/12) exhibited significantly lower ADC values than those showing progressive disease course. Conclusion: DWI with ADC mapping of extremity soft tissue tumors are so complicated that they alone may not be of much value in differentiating between benign and malignant tumors; however, it can be used as a tool for monitoring response to treatment.

Keywords

Diffusion-weighted imaging - post-therapeutic - soft tissue sarcomas

• References

• 1 Afonso PD, Kosinski AS, Spritzer CE. Following unenhanced MRI assessment for local recurrence after surgical resection of mesenchymal soft tissue tumors, do additional gadolinium-enhanced images change reader confidence or diagnosis?. Eur J Radiol 2013; 82: 806-13
• 2 Maeda M, Matsumine A, Kato H, Kusuzaki K, Maier SE, Uchida A. et al. Soft-tissue tumors evaluated by line-scan diffusion-weighted imaging: Influence of myxoid matrix on the apparent diffusion coefficient. J Magn Reson Imaging 2007; 25: 1199-204
• 3 Seierstad T, Røe K, Olsen DR. Noninvasive monitoring of radiation-induced treatment response using proton magnetic resonance spectroscopy and diffusion-weighted magnetic resonance imaging in a colorectal tumor model. Radiotherapy and Oncology 2007; 85: 187-94
• 4 Koh DM, Collins DJ. Diffusion-weighted MRI in the body: Applications and challenges in oncology. AJR Am J Roentgenol 2007; 188: 1622-35
• 5 Chhabra A, Soldatos T. Soft-tissue lesions: When can we exclude sarcoma?. AJR Am J Roentgenol 2012; 199: 1345-57
• 6 White LM, Wunder JS, Bell RS, O’Sullivan B, Catton C, Ferguson P. et al. Histologic assessment of peritumoral edema in soft tissue sarcoma. Int J Radiat Oncol Biol Phys 2005; 61: 1439-45
• 7 Subhawong TK, Jacobs MA, Fayad LM. Diffusion weighted MR imaging for characterizing musculoskeletal lesions. Radio Graphics 2014; 34.5: 1163-77
• 8 Khoo MM, Tyler PA, Saifuddin A, Padhani AR. Diffusion-weighted imaging (DWI) in musculoskeletal MRI: A critical review. Skeletal Radiol 2011; 40: 665-81
• 9 Subhawong TK, Durand DJ, Thawait GK, Jacobs MA, Fayad LM. Characterization of soft tissue masses: Can quantitative diffusion weighted imaging reliably distinguish cysts from solid masses?. Skeletal Radiol 2013; 42: 1583-92
• 10 Unal O, Koparan HI, Avcu S, Kalender AM, Kisli E. The diagnostic value of diffusion-weighted magnetic resonance imaging in soft tissue abscesses. Eur J Radiol 2011; 77: 490-4
• 11 Einarsdóttir H, Karlsson M, Wejde J, Bauer HC. Diffusion-weighted MRI of soft tissue tumors. Eur Radiol 2004; 14: 959-63
• 12 Nagata S, Nishimura H, Uchida M, Sakoda J, Tonan T, Hiraoka K. et al. Diffusion-weighted imaging of soft tissue tumors: Usefulness of the apparent diffusion coefficient for differential diagnosis. Radiat Med 2008; 26: 287-95
• 13 Oka K, Yakushiji T, Sato H, Fujimoto T, Hirai T, Yamashita Y. et al. Usefulness of diffusion-weighted imaging for differentiating between desmoid tumors and malignant soft tissue tumors. J Magn Reson Imaging 2011; 28: 1195-200
• 14 Razek A, Nada N, Ghaniem M, Elkhamary S. Assessment of soft tissue tumours of the extremities with diffusion echoplanar MR imaging. Radiol Med 2012; 117: 96-101
• 15 Schnapauff D, Zeile M, Niederhagen MB, Fleige B, Tunn PU, Hamm B. et al. Diffusion-weighted echo-planar magnetic resonance imaging for the assessment of tumor cellularity in patients with soft-tissue sarcomas. J Magn Reson Imaging 2009; 29: 1355-9
• 16 Dallaudière B, Lecouvet F, Van de Berg B, Omoumi P, Perlepe V, Cerny M. et al. Diffusion-weighted MR imaging in musculoskeletal diseases: Current concepts. Diagn Interv Imaging 2015; 96: 327-40
• 17 ElDaly MM, Moustafa AF, Abdel-Meguid SM, Shokry AM, El Wahab NA. Can MRI diffusion-weighted imaging identify postoperative residual/recurrent soft-tissue sarcomas?. Indian J Radiol Imaging 2018; 28: 70